Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S121-S126

  Gastañaduy, Paul A ^a   Contreras Roldán, Ingrid ^b   Bernart, Chris ^b   López, Beatriz ^b   Benoit, Stephen R ^c   Xuya, Marvin ^b   Muñoz, Fredy ^b   Desai, Rishi ^a   Quaye, Osbourne ^a,d   Tam, Ka Ian ^a   Evans Bowen, Diana K ^a   Parashar, Umesh D ^a   Patel, Manish ^a   McCracken, John P ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSIDAD DEL VALLE DE GUATEMALA   (Guatemala)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF GHANA   (Ghana)

Author keywords

gastroenteritis; Guatemala; rotavirus; vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE; VACCINE;

ARTICLE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; GUATEMALA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION; VIRUS STRAIN; CASE CONTROL STUDY; EVALUATION STUDY; HOSPITAL EMERGENCY SERVICE; HOSPITALIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; ODDS RATIO; POVERTY; PRESCHOOL CHILD; ROTAVIRUS; ROTAVIRUS INFECTIONS; STATISTICAL MODEL; VIROLOGY;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DIARRHEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUATEMALA; HOSPITALIZATION; HUMANS; INFANT; LOGISTIC MODELS; MALE; ODDS RATIO; POVERTY; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINE POTENCY; VACCINES, ATTENUATED;

EID: 84965181089     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1208     Document Type: Article

References (27)

1. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009; 84:533-40.
2. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: A randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9.
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22.
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
5. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
6. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
7. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23.
8. Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin 2010; 6:532-42.
9. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200(suppl 1):S39-48.
10. Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 2012; 12:561-70.
11. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340:c2825.
12. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-51.
13. Glass RI, Parashar U, Patel M, Gentsch J, Jiang B. Rotavirus vaccines: successes and challenges. J Infect 2014; 68(suppl 1):S9-18.
14. Banyai K, Laszlo B, Duque J, et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012; 30 (suppl 1):A122-30.
15. Hull JJ, Teel EN, Kerin TK, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30(1 suppl):S42-7.
16. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259-67.
17. Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America-a review. Mem Inst Oswaldo Cruz 2011; 106:907-11.
18. Castilla J, Beristain X, Martinez-Artola V, et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012; 30:539-43.
19. Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis 2013; 57:13-20.
20. Cortese MM, Immergluck LC, Held M, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013; 132:e25-33.
21. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63.
22. Bresee JS, Hummelman E, Nelson EA, Glass RI. Rotavirus in Asia: The value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 2005; 192(suppl 1):S1-5.
23. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305.
24. Cunliffe NA, Kilgore PE, Bresee JS, et al. Epidemiology of rotavirus diarrhoea in Africa: A review to assess the need for rotavirus immunization. Bull World Health Organ 1998; 76:525-37.
25. Patel M, Pedreira C, De Oliveira LH, et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012; 130:e365-72.
26. Cunliffe NA, Witte D, Ngwira BM, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial. Vaccine 2012; 30(suppl 1): A36-43.
27. Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis 2013; 208:284-94.